These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Comparative Analysis of PEG-Free and PEG-Based Self-Emulsifying Drug Delivery Systems for Enhanced Oral Bioavailability of Therapeutic (Poly) Peptides. Haddadzadegan S, To D, Matteo Jörgensen A, Wibel R, Laffleur F, Bernkop-Schnürch A. Small; 2024 Jul; 20(27):e2307618. PubMed ID: 38308358 [Abstract] [Full Text] [Related]
8. [Design, optimization and quality evaluation of curcumin self-emulsifying drug delivery system (SEDDS)]. Wang YH, Wang SH, Yang RP, Ma XJ. Zhong Yao Cai; 2010 Dec; 33(12):1933-7. PubMed ID: 21548374 [Abstract] [Full Text] [Related]
9. Development and in vitro evaluation of zeta potential changing self-emulsifying drug delivery systems for enhanced mucus permeation. Suchaoin W, Pereira de Sousa I, Netsomboon K, Lam HT, Laffleur F, Bernkop-Schnürch A. Int J Pharm; 2016 Aug 20; 510(1):255-62. PubMed ID: 27329673 [Abstract] [Full Text] [Related]
10. Phosphorylated PEG-emulsifier: Powerful tool for development of zeta potential changing self-emulsifying drug delivery systems (SEDDS). Wolf JD, Kurpiers M, Götz RX, Zaichik S, Hupfauf A, Baecker D, Gust R, Bernkop-Schnürch A. Eur J Pharm Biopharm; 2020 May 20; 150():77-86. PubMed ID: 32151729 [Abstract] [Full Text] [Related]
11. Trypsin decorated self-emulsifying drug delivery systems (SEDDS): Key to enhanced mucus permeation. Shahzadi I, Dizdarević A, Efiana NA, Matuszczak B, Bernkop-Schnürch A. J Colloid Interface Sci; 2018 Dec 01; 531():253-260. PubMed ID: 30036849 [Abstract] [Full Text] [Related]
12. Improving solubility and oral bioavailability of a novel antimalarial prodrug: comparing spray-dried dispersions with self-emulsifying drug delivery systems. Potharaju S, Mutyam SK, Liu M, Green C, Frueh L, Nilsen A, Pou S, Winter R, Riscoe MK, Shankar G. Pharm Dev Technol; 2020 Jun 01; 25(5):625-639. PubMed ID: 32031478 [Abstract] [Full Text] [Related]
13. Highly mucus permeating and zeta potential changing self-emulsifying drug delivery systems: A potent gene delivery model for causal treatment of cystic fibrosis. Griesser J, Hetényi G, Federer C, Steinbring C, Ellemunter H, Niedermayr K, Bernkop-Schnürch A. Int J Pharm; 2019 Feb 25; 557():124-134. PubMed ID: 30594687 [Abstract] [Full Text] [Related]
15. Self-emulsifying drug delivery systems and cationic surfactants: do they potentiate each other in cytotoxicity? Lam HT, Le-Vinh B, Phan TNQ, Bernkop-Schnürch A. J Pharm Pharmacol; 2019 Feb 25; 71(2):156-166. PubMed ID: 30251762 [Abstract] [Full Text] [Related]
16. Effects of excipients on the interactions of self-emulsifying drug delivery systems with human blood plasma and plasma membranes. Le-Vinh B, Le NN, Phan TNQ, Lam HT, Bernkop-Schnürch A. Drug Deliv Transl Res; 2024 Nov 25; 14(11):3200-3211. PubMed ID: 38411893 [Abstract] [Full Text] [Related]
17. Novel self-emulsifying formulation of quercetin for improved in vivo antioxidant potential: implications for drug-induced cardiotoxicity and nephrotoxicity. Jain S, Jain AK, Pohekar M, Thanki K. Free Radic Biol Med; 2013 Dec 25; 65():117-130. PubMed ID: 23792276 [Abstract] [Full Text] [Related]
18. Thiolation of non-ionic surfactants for the development of lipid-based mucoadhesive drug delivery systems. Racaniello GF, Knoll P, Jörgensen AM, Arduino I, Laquintana V, Lopedota AA, Bernkop-Schnürch A, Denora N. Eur J Pharm Biopharm; 2022 Oct 25; 179():95-104. PubMed ID: 36058444 [Abstract] [Full Text] [Related]
19. Development of a new class of sulforaphane-enabled self-emulsifying drug delivery systems (SFN-SEDDS) by high throughput screening: A case study with curcumin. Kamal MM, Nazzal S. Int J Pharm; 2018 Mar 25; 539(1-2):147-156. PubMed ID: 29414123 [Abstract] [Full Text] [Related]